Sialorrhea Treatment Market Size and Forecast (2020–2030) – Global and Regional Share, Trend, and Growth Opportunity Analysis – by Medical Therapy (Pharmacologic Therapy and Radiotherapy) and End User (Hospitals, Specialty Clinics, Homecare Settings, and Others), and Geography
According to our latest study on “Sialorrhea Treatment Market Forecast to 2030 – Global Analysis – by Medical Therapy and End User,” the market was valued at US$ 695.06 million in 2022 and is expected to reach US$ 1,042.37 million by 2030; it is estimated to record a CAGR of 5.2% from 2022 to 2030. The market growth is attributed to the increasing prevalence of neurodegenerative disorders and the availability of various treatment options for sialorrhea. Moreover, rising research and development (R&D) and new drug approvals will likely fuel the sialorrhea treatment market growth in the coming years. However, challenges related to sialorrhea treatment restrain the market growth.
Download Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00033418/
Medical Therapy-Based Insights
Based on medical therapy, the sialorrhea treatment market is segmented into pharmacologic therapy, radiotherapy, and others. In 2022, the pharmacologic therapy segment held the largest market share. Also, the segment is expected to record the highest CAGR from 2022 to 2030. Vaccines provide active acquired immunity against particular infectious diseases. In multiple independent clinical trials, pharmacological treatments such as benztropine, glycopyrrolate, scopolamine, and botulinum toxins have been demonstrated to be effective in managing sialorrhea. Medications are delivered orally or parenterally. Botulinum toxin is injected into the salivary gland guided by anatomical external palpation or ultrasonography.
End User-Based Insights
The sialorrhea treatment market, by end-user, is segmented into hospitals, specialty clinics, home care settings, and others. The hospitals segment held the largest market share in 2022 and is anticipated to record the highest CAGR during 2022–2030. The treatment for sialorrhea is done in hospitals through appropriate treatment and motor therapy, with the help of highly experienced interdisciplinary medical specialists, including physiotherapists and neurology specialists.
A few of the major primary and secondary sources referred to while preparing the report on the sialorrhea treatment market are the World Health Organization (WHO) and the Parkinson’s Foundation, among others.
About Us:
The Insight Partners is a market research solution and consultation company. Specializing in syndicate market research, our team helps clients in their hunt for revenue pockets in several industries. A team of 250+ research experts is dedicated to offering the most relevant, data-driven, and trustworthy market insights and consultation.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us
The Insight Partners
Phone: +1-646-491-9876
E-mail: [email protected]
About Author
